Runny Nose & COVID-19: What You Need to Know
Could a common Cold Virus Offer Some Protection Against COVID-19?
Recent research suggests a surprising link between rhinoviruses – the culprits behind the common cold – and a degree of protection against COVID-19. A large-scale study conducted in the United States between May 2020 and February 2021 revealed this unexpected connection.

Scientists observed that individuals who had recently been infected with a rhinovirus exhibited a heightened, though not complete, immune response that also worked against SARS-CoV-2, the virus that causes COVID-19. This isn’t to say catching a cold *prevents* COVID-19, but it suggests prior exposure to a rhinovirus can prime the immune system.
How Does This Protection Work?
The key appears to lie in the activation of the body’s innate immune system
. Rhinoviruses are known to trigger this non-specific immune response – the body’s first line of defense. This initial activation seems to put the immune system on alert, making it more readily able to respond to other viral threats, including SARS-CoV-2.
Think of it like a fire alarm. A small fire (rhinovirus) sets off the alarm (innate immune system),preparing the building (your body) for a larger fire (SARS-CoV-2). The alarm doesn’t prevent the larger fire, but it ensures a faster and more effective response.
Study details and Limitations
The study involved regular health assessments, including recess examinations, of a large cohort of participants. Data collected between May 2020 and February 2021 provided the basis for these findings. While the results are promising, it’s crucial to note that this is a complex area of research.
| Study Period | Key finding |
|---|---|
| May 2020 – February 2021 | Rhinovirus infection associated with partial protection against COVID-19. |
Further research is needed to determine the strength and duration of this protective effect, as well as the specific mechanisms involved. It’s also important to understand how different rhinovirus strains might impact the immune response.
